| Source: |
| Type: |
| HMGCS2 - 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Abbreviation: HMGCS2, mitochondrial HMG-CoA synthase Type: Mitochondrial metabolic enzyme / ketogenesis enzyme Function: Catalyzes the condensation of acetyl-CoA with acetoacetyl-CoA to form HMG-CoA and is the rate-limiting enzyme of mitochondrial ketogenesis. HMGCS2 regulates production of ketone bodies including β-hydroxybutyrate and acetoacetate and links fatty-acid oxidation, mitochondrial metabolism, cellular energy status, and metabolic signaling. Cancer: ↕ Context-dependent. HMGCS2 functions as a tumor suppressor in several cancers, where reduced expression can promote proliferation, migration, invasion, and tumor progression and restoration of HMGCS2 can suppress malignant behavior. However, HMGCS2-dependent ketogenesis can support metabolic adaptation and survival in selected tumor contexts, making its role dependent on cancer type and metabolic state. |
| 7483- | H2, | Cisplatin, | Molecular hydrogen attenuates cisplatin-induced nephrotoxicity by modulating β-hydroxybutyrate metabolism |
| - | in-vivo, | Nor, | HK-2 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1646 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid